JRJulia Rokosz

Julia Rokosz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Rokosz has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Current Therapeutic Strategies for Obesity in the Pediatric Population: A Literature Review

    by Julia Rokosz, Krzysztof Mazur, Sandra Michałek, Julianna Koczuk, Katarzyna Sładek, Alicja Trzepizur, Monika Spaczyńska-Kwiatkowska

    Background: Childhood obesity is a major public health problem in both developing and developed countries. It is a chronic, complex, and progressive disease influenced by multiple genetic, psychological, dietary, familial, environmental, and biological factors. It is associated with a wide range of short- and long-term multiorgan complications, many of which persist into adulthood, increasing the risk of chronic multimorbidity. Therefore, early prevention and appropriate treatment are essential. Aim: To review current therapeutic strategies for pediatric obesity, focusing on lifestyle and behavioral interventions, pharmacotherapy, and bariatric surgery, and to evaluate their effectiveness and clinical applicability. Materials and methods: A literature review was conducted using PubMed, the Cochrane Library, and Google Scholar, focusing mainly on studies published after 2020 addressing lifestyle, psychological, pharmacological, and surgical management of obesity in children and adolescents. Results: The therapeutic approach is holistic, based on sustainable lifestyle modification, including dietary changes, physical activity, reduced sedentary behavior, and family involvement. Cognitive-behavioral therapy is crucial in modifying maladaptive behaviors. Pharmacotherapy has expanded options, with GLP-1 receptor agonists (semaglutide, liraglutide) showing the greatest effectiveness, while orlistat, phentermine/topiramate, and setmelanotide may provide additional benefit. Bariatric surgery remains the most effective intervention for severe adolescent obesity, resulting in substantial and sustained weight loss. Conclusions: Management should be multidisciplinary, with individualized behavioral and psychological interventions as the foundation. Pharmacotherapy and bariatric surgery should be considered in selected patients with severe obesity or inadequate response to conservative treatment.

  • Open Access

    Current Treatment Strategies for Irritable Bowel Syndrome - A Literature Review

    by Sandra Michałek, Julia Rokosz, Katarzyna Sładek, Julianna Koczuk, Krzysztof Mazur, Alicja Trzepizur, Bartosz Wnorowski

    Background. Irritable bowel syndrome is one of the most common chronic gastrointestinal disorders. This disease is diagnosed worldwide, although it is much more common in developed countries. The main role in the development of the disease is attributed to dysfunction of the brain-gut axis and factors such as intestinal microbiota dysbiosis and prolonged exposure to stress. The symptoms significantly reduce the quality of life of patients, which is why it is so important to develop clear recommendations for better control of the condition. Aim. The aim of this study was to analyse and summarise current pharmacological and non-pharmacological strategies for treating irritable bowel syndrome. Materials and methods. A review of the literature available in the PubMed, Google Scholar and Cochrane databases was conducted. Articles published between 2012-2025 were considered. Publications of low methodological quality and those containing incomplete data were excluded. Results. According to research, the best dietary intervention is a low-FODMAP diet, but it should be followed under the supervision of an experienced dietitian. Probiotics should be considered as first-line medications. A growing number of publications point to the beneficial effects of psychotherapy, regular moderate-intensity physical activity, and healthy eating habits, especially regular consumption of small meals. The impact of quality sleep and stress management skills on prolonging IBS remission is also emphasized, but the scientific evidence is not yet strong enough. Conclusions. Changes in diet and eating habits have been shown to be important in reducing symptoms and prolonging remission. There are many pharmacological options available, but there are no clear guidelines due to the complex pathomechanism of the disease. Currently, probiotics are the most recommended treatment. Herbal therapies, psychotherapy, mindfulness techniques, physical activity should be considered as additional support.